Navigation Links
Considering Lung Transplant, Award Winning Singer-Songwriter with Rare Lung Disease Returns to Stage at Pulmonary Hypertension Association Event Nov. 7
Date:11/6/2013

New York, NY (PRWEB) November 06, 2013

The Pulmonary Hypertension Association’s (PHA) 1st Annual New York City O2 breathe Gala will honor the legacy of Dr. Robyn Barst and will feature 2011 AVON National and International Songwriting Competition Winner, singer-songwriter Chloe Temtchine. Mere months after her diagnosis of pulmonary hypertension (PH) caused by PVOD, Ms. Temtchine will valiantly launch her "No Pressure Tour" with a performance at the event, singing while using her oxygen tank which she affectionately calls “Steve Martin.” Craig Melvin will serve as Master of Ceremonies.

WHO: PHA's Greater New York Chapter

WHAT: PHA's 1st Annual New York City O2 breathe Gala

WHERE: The Lighthouse; Chelsea Piers Pier 61; New York, NY

WHEN: Thursday, November 7, 2013.
                    Reception and Step and Repeat Photos 6:30-7:30 PM
                    Dinner 7:30 PM
                    Ms. Temtchine’s Performance 8:30 PM

WHY: To raise funds and awareness to fight pulmonary hypertension. PH is high
                    blood pressure in the artieres of the lungs that can lead to heart failure.

PHOTO AND INTERVIEW OPPORTUNITIES:
Craig Melvin, MSNBC Anchor and NBC News Correspondent
Chloe Temtchine, PH patient and singer who will perform using her oxygen tank
Jennifer Lombardi, PH patient and dancer who will perform a salsa dance

Tickets and additional information available at http://www.O2breathe.org/nycgala.

PHA is the country's leading organization connecting pulmonary hypertension patients, families, and medical professionals. Its mission is to find ways to prevent and cure pulmonary hypertension and provide hope for the community through support, education, research, advocacy and awareness. PHA provides free access to information on its website about pulmonary hypertension and facilitates over 240 support groups around the nation. PHA is proud to have met the BBB Wise Giving Alliance Standards for Charity Accountability. Additionally, for ten consecutive years, PHA has received the highest possible rating-4 stars-for fiscal accountability and transparency from Charity Navigator, placing PHA in the top 1% of all rated charities. 88.5% of funds raised by PHA go directly to research and our support, education, advocacy and awareness efforts. To learn more about PHA, visit: http://www.PHAssociation.org.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11306174.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Considering Transplant and on Oxygen, Singer-Songwriter with Rare Lung Disease Returns to Stage Nov. 7, Pulmonary Hypertension Association Announces
2. Federal Judicial Panel Considering Byetta Lawsuit Consolidation, Rottenstein Law Group LLP Reports
3. Stryker Hip Lawsuit News: Those Considering Filing Lawsuits Need to Heed Statutes of Limitation, Rottenstein Law Group LLP Reports
4. Newport Board Group, a National Business Advisory Firm of CEOs That Serves the Middle Market, Issues Guidance for Companies Considering a Sale in 2013
5. Long-Time-Liner® Beverly Hills advises on the key points to seek in a qualified technician for those considering the newly emerging permanent make-up trend.
6. Cosmetic Vaginal Surgeons, Dr. Miklos and Dr. Moore evaluate the preoperative perceptions and postoperative expectations of 550 patients who are considering a labiaplasty
7. When considering bariatric surgery think about bones
8. Medical Tourism: Uncharted Territory for Patients James Goldberg, Author of the American Medical Money Machine, Is Offering a New Consulting Service to Medical Patients Considering “Medical Tourism” Treatment
9. For lung transplant, researchers surprised to learn bigger appears to be better
10. HIV No Barrier to Getting Liver Transplant, Study Finds
11. The Global Awards World’s Best Healthcare Advertising Hosts Celebrations in New York City & Sydney, Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a provider ... and other difficult to transfect cells, announces its launch of the PluriQ™ G9™ ... Editing System is a complete system for culturing and transfecting human pluripotent ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: